Global Corticosteroids API Market Research Report 2023

Global Corticosteroids API Market Research Report 2023

The global Corticosteroids API market was valued at US$ 2206.26 million in 2022 and is anticipated to reach US$ 3309.40 million by 2029, witnessing a CAGR of 6.11% during the forecast period 2023-2029.

North American market for Corticosteroids API is estimated to increase from $ 220.53 million in 2022 to reach $ 302.18 million by 2029, at a CAGR of 4.69 % during the forecast period of 2023 through 2029.

Europe market for Corticosteroids API is estimated to increase from $ 512.79 million in 2022 to reach $ 708.19 million by 2029, at a CAGR of 4.74 % during the forecast period of 2023 through 2029.

The major global manufacturers of Corticosteroids API include Pfizer CentreOne, EUROAPI, GlaxoSmithKline, Teva Pharmaceutical Industries, Hovione, Axplora, Steroid SpA, Avik Pharmaceutical, and Anuh Pharma, etc. In 2022, the world's top three vendors accounted for approximately 30.09% of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Corticosteroids API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Corticosteroids API.

The Corticosteroids API market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Corticosteroids API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Corticosteroids API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

Pfizer CentreOne

EUROAPI

GlaxoSmithKline

Teva Pharmaceutical Industries

Hovione

Axplora

Steroid SpA

Avik Pharmaceutical

Anuh Pharma

Symbiotec Pharmalab

Sun Pharmaceutical

Cipla

Wellona Pharma

Tianjin Tianyao Pharmaceuticals

Zhejiang Xianju Pharmaceutical

Guangdong VTR BioTech

Zhejiang Xianju Xianle Pharmaceutical

Tianjin Pacific Pharmaceutical

Shandong Xinhua Pharmaceutica Group

Jiangsu Lianhuan Pharmaceutical

Shanghai New Hualian Pharmaceutical

Shandong Taihua Biotech

Shandong Sito Bio-technolog

Zhejiang Xianju Junye Pharmaceutical

Segment by Type

Prednisone Series

Dexamethasone Series

Betamethasone Series

Hydrocortisone Series

Other

Segment by Application

Injectable Drugs

Oral Drugs

Topical Drugs

Inhaled Drugs

Production by Region

North America

Europe

China

Japan

Consumption by Region

North America

U.S.

Canada

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Europe

Germany

France

U.K.

Italy

Russia

Rest of Europe

South America

Mexico

Brazil

Rest of South America

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Corticosteroids API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Production/output, value of Corticosteroids API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 4: Consumption of Corticosteroids API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: The main points and conclusions of the report.